GSK Investigational Site — Oklahoma City, Oklahoma

GSK Investigational Site is a clinical research site located in Oklahoma City, Oklahoma, United States 73104.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 224 clinical trials with 11 currently active.

Therapeutic areas: Arthritis, Rheumatoid, Epilepsy, Epilepsy, Partial.

Sponsors: GlaxoSmithKline, XenoPort, Inc., Human Genome Sciences Inc., a GSK Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 224 clinical trials on record, with 11 currently active. Their work covers Arthritis, Rheumatoid, Epilepsy, Epilepsy, Partial.

Is GSK Investigational Site accredited by Crixeo Clinical Trials?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.